KYMR logo

Kymera Therapeutics, Inc. (KYMR) Cash From Investing

Annual CFI:

-$404.08M-$543.96M(-388.86%)
December 31, 2024

Summary

  • As of today, KYMR annual cash from investing is -$404.08 million, with the most recent change of -$543.96 million (-388.86%) on December 31, 2024.
  • During the last 3 years, KYMR annual cash from investing has fallen by -$304.24 million (-304.74%).
  • KYMR annual cash from investing is now -388.86% below its all-time high of $139.89 million, reached on December 31, 2023.

Performance

KYMR Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKYMRcash flow metrics

Quarterly CFI:

-$235.30M-$295.32M(-492.03%)
September 30, 2025

Summary

  • As of today, KYMR quarterly cash from investing is -$235.30 million, with the most recent change of -$295.32 million (-492.03%) on September 30, 2025.
  • Over the past year, KYMR quarterly cash from investing has dropped by -$77.62 million (-49.23%).
  • KYMR quarterly cash from investing is now -387.64% below its all-time high of $81.80 million, reached on June 30, 2022.

Performance

KYMR Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKYMRcash flow metrics

TTM CFI:

-$58.09M-$77.62M(-397.56%)
September 30, 2025

Summary

  • As of today, KYMR TTM cash from investing is -$58.09 million, with the most recent change of -$77.62 million (-397.56%) on September 30, 2025.
  • Over the past year, KYMR TTM cash from investing has increased by +$395.60 million (+87.20%).
  • KYMR TTM cash from investing is now -141.53% below its all-time high of $139.89 million, reached on December 31, 2023.

Performance

KYMR TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKYMRcash flow metrics

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

KYMR Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-388.9%-49.2%+87.2%
3Y3 Years-304.7%-527.8%-2782.1%
5Y5 Years-2351.0%+29.6%+83.7%

KYMR Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-388.9%at low-443.2%+28.8%-141.5%+87.2%
5Y5-Year-388.9%+4.4%-387.6%+29.6%-141.5%+87.2%
All-TimeAll-Time-388.9%+4.4%-387.6%+29.6%-141.5%+87.2%

KYMR Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2025
-
-$235.30M(-492.0%)
-$58.09M(-397.6%)
Jun 2025
-
$60.02M(+23.5%)
$19.52M(+178.6%)
Mar 2025
-
$48.62M(-29.1%)
-$24.86M(+93.8%)
Dec 2024
-$404.08M(-388.9%)
$68.57M(+143.5%)
-$404.08M(+10.9%)
Sep 2024
-
-$157.68M(-1108.1%)
-$453.69M(-92.6%)
Jun 2024
-
$15.64M(+104.7%)
-$235.50M(-9.4%)
Mar 2024
-
-$330.61M(-1844.4%)
-$215.31M(-253.9%)
Dec 2023
$139.89M(+581.7%)
$18.95M(-68.7%)
$139.89M(+96.3%)
Sep 2023
-
$60.51M(+68.8%)
$71.27M(+366.7%)
Jun 2023
-
$35.84M(+45.8%)
-$26.72M(-238.9%)
Mar 2023
-
$24.58M(+149.5%)
$19.24M(-6.2%)
Dec 2022
$20.52M
-$49.67M(-32.5%)
$20.52M(+847.3%)
DateAnnualQuarterlyTTM
Sep 2022
-
-$37.48M(-145.8%)
$2.17M(+102.2%)
Jun 2022
-
$81.80M(+216.3%)
-$97.22M(+17.8%)
Mar 2022
-
$25.86M(+138.0%)
-$118.30M(-18.5%)
Dec 2021
-$99.83M(+76.4%)
-$68.02M(+50.3%)
-$99.83M(-178.8%)
Sep 2021
-
-$136.86M(-325.4%)
-$35.81M(+84.7%)
Jun 2021
-
$60.72M(+37.0%)
-$233.26M(+31.6%)
Mar 2021
-
$44.32M(+1210.9%)
-$340.86M(+19.3%)
Dec 2020
-$422.59M(-2463.3%)
-$3.99M(+98.8%)
-$422.59M(-18.5%)
Sep 2020
-
-$334.32M(-613.2%)
-$356.64M(-1498.0%)
Jun 2020
-
-$46.87M(-25.3%)
-$22.32M(-190.9%)
Mar 2020
-
-$37.40M(-160.4%)
$24.56M(-60.4%)
Dec 2019
-$16.49M(-1115.8%)
$61.96M
$61.96M
Dec 2018
-$1.36M
-
-

FAQ

  • What is Kymera Therapeutics, Inc. annual cash from investing?
  • What is the all-time high annual cash from investing for Kymera Therapeutics, Inc.?
  • What is Kymera Therapeutics, Inc. annual cash from investing year-on-year change?
  • What is Kymera Therapeutics, Inc. quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for Kymera Therapeutics, Inc.?
  • What is Kymera Therapeutics, Inc. quarterly cash from investing year-on-year change?
  • What is Kymera Therapeutics, Inc. TTM cash from investing?
  • What is the all-time high TTM cash from investing for Kymera Therapeutics, Inc.?
  • What is Kymera Therapeutics, Inc. TTM cash from investing year-on-year change?

What is Kymera Therapeutics, Inc. annual cash from investing?

The current annual cash from investing of KYMR is -$404.08M

What is the all-time high annual cash from investing for Kymera Therapeutics, Inc.?

Kymera Therapeutics, Inc. all-time high annual cash from investing is $139.89M

What is Kymera Therapeutics, Inc. annual cash from investing year-on-year change?

Over the past year, KYMR annual cash from investing has changed by -$543.96M (-388.86%)

What is Kymera Therapeutics, Inc. quarterly cash from investing?

The current quarterly cash from investing of KYMR is -$235.30M

What is the all-time high quarterly cash from investing for Kymera Therapeutics, Inc.?

Kymera Therapeutics, Inc. all-time high quarterly cash from investing is $81.80M

What is Kymera Therapeutics, Inc. quarterly cash from investing year-on-year change?

Over the past year, KYMR quarterly cash from investing has changed by -$77.62M (-49.23%)

What is Kymera Therapeutics, Inc. TTM cash from investing?

The current TTM cash from investing of KYMR is -$58.09M

What is the all-time high TTM cash from investing for Kymera Therapeutics, Inc.?

Kymera Therapeutics, Inc. all-time high TTM cash from investing is $139.89M

What is Kymera Therapeutics, Inc. TTM cash from investing year-on-year change?

Over the past year, KYMR TTM cash from investing has changed by +$395.60M (+87.20%)
On this page